Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Silymarin on Non Alcoholic Steatohepatitis
IRCT138805172308N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by Mazandaran University of Medical Sciences. Started Aug 2009; status: completed.
02
Drugs
silymarin
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on IRCT138805172308N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138805172308N1.